Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria

_MG_7006_HD.jpg

Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria (1) (Source: Novartis | 2 months ago)

Image
_MG_7046_HD.jpg

Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria (2) (Source: Novartis | 2 months ago)

Image
_Z1E6473_HD.jpg

Novartis and Medicines for Malaria Venture report positive results for Phase 2b study of novel ganaplacide/lumefantrine combination in children with malaria (3) (Source: Novartis | 2 months ago)

Image